Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Shenzhen Third People’s Hospital · Xiamen University · +1 more institution
Indexed incrossrefpubmed
Abstract
Background
The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patients remains largely unknown, and the clinical value of antibody testing has not been fully demonstrated.
Methods
173 patients with SARS-CoV-2 infection were enrolled. Their serial plasma samples (n = 535) collected during hospitalization were tested for total antibodies (Ab), IgM, and IgG against SARS-CoV-2. The dynamics of antibodies with disease progress were analyzed.
Citation impact
2,669
total citations
- FWCI
- 64.61
- Percentile
- 100%
- References
- 13
Citations per year
Authors
25Topics & keywords
Topics
Keywords
- Seroconversion
- Medicine
- Antibody
- Titer
- Immunology
- Immunoglobulin M
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Coronavirus disease 2019 (COVID-19)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.